Literature DB >> 11571708

Commentary: minimal residual disease: how low do we go?

A Bagg1.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11571708     DOI: 10.1054/modi.2001.26157

Source DB:  PubMed          Journal:  Mol Diagn        ISSN: 1084-8592


× No keyword cloud information.
  4 in total

Review 1.  Chronic myeloid leukemia: a minimalistic view of post-therapeutic monitoring.

Authors:  Adam Bagg
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

2.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

3.  Immunoglobulin heavy chain gene analysis in lymphomas: a multi-center study demonstrating the heterogeneity of performance of polymerase chain reaction assays.

Authors:  Adam Bagg; Rita M Braziel; Daniel A Arber; Karen E Bijwaard; Albert Y Chu
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

4.  Multiplex RT-PCR for the detection of leukemia-associated translocations: validation and application to routine molecular diagnostic practice.

Authors:  Manuel Salto-Tellez; Suresh G Shelat; Bernice Benoit; Hanna Rennert; Martin Carroll; Debra G B Leonard; Peter Nowell; Adam Bagg
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.